Kernal Biologics, Inc. — Form D
Kernal Biologics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-25. The offering totals $25.5M, of which $20.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-25
- Form: D
- Accession: 0001684728-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.5M
- Amount sold: $20.1M
- Remaining: $5.4M
- Investors: 53
- Date of first sale: 2022-02-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-435030
Issuer
- Name: Kernal Biologics, Inc.
- CIK: 0001684728
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 700 MAIN STREET, CAMBRIDGE, MA, 02139
- Phone: 781-999-4008
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Yusuf Erkul | Director | Cambridge, MA |
| Burak Yilmaz | Director | Cambridge, MA |
| Yusuf Erkul | Executive Officer | Cambridge, MA |
| Burak Yilmaz | Executive Officer | Cambridge, MA |
| Oguzhan Yilmaz | Director | Cambridge, MA |
| Catherine Moroski | Director | Cambridge, MA |
| Catherine Moroski | Executive Officer | Cambridge, MA |
| Oguzhan Yilmas | Director | Cambridge, MA |
Other filings by this issuer (2)
More